Overview

Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and efficacy of RGH-896 in patients with diabetic peripheral neuropathic pain.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Gedeon Richter Ltd.
Treatments:
Pregabalin